Citadel Advisors »

Prime Medicine shares owned by Citadel Advisors

Quarter-by-quarter ownership of Prime Medicine (PRME) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Prime Medicine

Tip: Access up to 7 years of quarterly data

All positions including Prime Medicine held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prime Medicine by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $380k 43k 8.86
2023-09-30 $169k 18k 9.54

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Prime Medicine

Alphabet
ARK Investment Management
Vanguard Group
Nikko Asset Management Americas
Sumitomo Mitsui Trust Holdings
T. Rowe Price Associates
Redmile Group
Baker Bros. Advisors
Deerfield Management Company
Greenwich Wealth Management
Bank of America Corporation
Samsara BioCapital
Casdin Capital
Charles Schwab Investment Management
Two Sigma Investments

View all funds holding Prime Medicine